Virginia Retirement Systems’s Sage Therapeutics SAGE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$885K	Buy	43,000 +1,900	+5%	+$54.9K	0.01%	543
2023 Q2	$1.93M	Buy	41,100 +8,400	+26%	+$418K	0.02%	363
2023 Q1	$1.37M	Buy	32,700 +1,900	+6%	+$81.7K	0.01%	449
2022 Q4	$1.17M	Buy	30,800 +2,100	+7%	+$80.2K	0.01%	566
2022 Q3	$1.12M	Buy	+28,700	New	+$1.11M	0.01%	539
2022 Q1	$1.08M	Sell	32,500 -3,400	-9%	-$128K	0.01%	616
2021 Q4	$1.53K	Sell	35,900 -4,100	-10%	-$172K	0.01%	513
2021 Q3	$1.77M	Buy	40,000 +1,200	+3%	+$55K	0.02%	460
2021 Q2	$2.2M	Buy	38,800 +24,800	+177%	+$1.75M	0.02%	424
2021 Q1	$1.05M	Buy	14,000 +7,800	+126%	+$640K	0.01%	644
2020 Q4	$536K	Sell	6,200 -2,300	-27%	-$170K	0.01%	819
2020 Q3	$520K	Sell	8,500 -2,000	-19%	-$101K	0.01%	752
2020 Q2	$437K	Buy	10,500 +2,800	+36%	+$102K	0.01%	847
2020 Q1	$221K	Buy	7,700 +300	+4%	+$17.4K	﹤0.01%	1001
2019 Q4	$534K	Buy	7,400 +1,800	+32%	+$221K	0.01%	908
2019 Q3	$786K	Buy	5,600 +1,600	+40%	+$268K	0.01%	772
2019 Q2	$732K	Sell	4,000 -400	-9%	-$68.3K	0.01%	789
2019 Q1	$700K	Buy	4,400 +1,700	+63%	+$246K	0.01%	799
2018 Q4	$259K	Buy	+2,700	New	+$309K	﹤0.01%	1014